Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for ASTH

Stock Name	Astrana Health Inc
Ticker	ASTH(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US03763A2078
LEI	5493008O4R82Q4STJ936

Show aggregate ASTH holdings

News associated with ASTH

Rep. Judy Chu Buys Astrana Health, Inc. (NASDAQ:ASTH) Shares: Representative Judy Chu (D-California) recently bought shares of Astrana Health, Inc. (NASDAQ:ASTH). In a filing disclosed on August 30th, the Representative disclosed that they had bought between $100,001 and $250,000 in Astrana Health stock on August 19th. Representative Judy Chu also recently made the following trade(s): Sold $100,001 – $250,000 in shares of Astrana Health […] - 2025-09-02 03:03:14
Reviewing Astrana Health (NASDAQ:ASTH) & The Pennant Group (NASDAQ:PNTG): Astrana Health (NASDAQ:ASTH – Get Free Report) and The Pennant Group (NASDAQ:PNTG – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Institutional and Insider Ownership 52.8% of […] - 2025-08-26 05:34:53
Critical Comparison: Astrana Health (NASDAQ:ASTH) and Fresenius SE & Co. (OTCMKTS:FSNUY): Astrana Health (NASDAQ:ASTH – Get Free Report) and Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. Analyst Recommendations This is a summary […] - 2025-08-19 04:26:49
Noteworthy Monday Option Activity: ASTH, PLTR, INTC: Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Astrana Health Inc (Symbol: ASTH), where a total volume of 5,461 contracts has been traded thus far today, a contract volume which is representative of approxima - 2025-08-18 16:18:40
Maryland State Retirement & Pension System Has $375,000 Stock Position in Astrana Health, Inc. (NASDAQ:ASTH): Maryland State Retirement & Pension System lowered its position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 13.7% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,099 shares of the company’s stock after selling 1,927 shares during […] - 2025-08-17 05:17:02
Natixis Advisors LLC Grows Stock Holdings in Astrana Health, Inc. (NASDAQ:ASTH): Natixis Advisors LLC lifted its position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,622 shares of the company’s stock after purchasing an additional 3,462 shares during the […] - 2025-08-11 05:12:52
Bank of New York Mellon Corp Sells 13,624 Shares of Astrana Health, Inc. (NASDAQ:ASTH): Bank of New York Mellon Corp lessened its position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 5.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 253,252 shares of the company’s stock after selling 13,624 shares during the period. Bank of […] - 2025-07-23 05:08:52
Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Louisiana State Employees Retirement System: Louisiana State Employees Retirement System decreased its position in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 2.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,600 shares of the company’s stock after selling 500 shares during the quarter. Louisiana State […] - 2025-07-21 05:16:48
Reviewing Astrana Health (NASDAQ:ASTH) & Montrose Environmental Group (NYSE:MEG): Montrose Environmental Group (NYSE:MEG – Get Free Report) and Astrana Health (NASDAQ:ASTH – Get Free Report) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings. Analyst Recommendations This is a […] - 2025-06-10 02:58:49
Astrana Health, Inc. (NASDAQ:ASTH) Receives Average Rating of “Moderate Buy” from Analysts: Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nine brokerages that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year target price among brokers […] - 2025-06-10 02:28:55
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in Astrana Health, Inc. (NASDAQ:ASTH): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 15.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 104,658 shares of the company’s stock after acquiring an additional 14,138 shares during the period. UBS AM a distinct […] - 2025-06-06 05:16:54
Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by BNP Paribas Financial Markets: BNP Paribas Financial Markets lowered its stake in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 43.0% during the fourth quarter, Holdings Channel.com reports. The fund owned 5,638 shares of the company’s stock after selling 4,249 shares during the quarter. BNP Paribas Financial Markets’ holdings in Astrana Health were worth $178,000 at the end of […] - 2025-05-30 04:27:00
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Raises Position in Astrana Health, Inc. (NASDAQ:ASTH): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 3.9% during the 4th quarter, Holdings Channel reports. The institutional investor owned 24,505 shares of the company’s stock after buying an additional 915 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in […] - 2025-05-28 04:50:54
State of Wyoming Lowers Stock Holdings in Astrana Health, Inc. (NASDAQ:ASTH): State of Wyoming lessened its position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 53.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,873 shares of the company’s stock after selling 4,421 shares during the period. […] - 2025-05-27 05:18:56
Astrana Health, Inc. (NASDAQ:ASTH) Shares Acquired by Northern Trust Corp: Northern Trust Corp lifted its position in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 10.1% in the 4th quarter, HoldingsChannel.com reports. The firm owned 467,179 shares of the company’s stock after acquiring an additional 43,032 shares during the quarter. Northern Trust Corp’s holdings in Astrana Health were worth $14,730,000 as of its most recent […] - 2025-05-16 05:20:50
Astrana Health, Inc. (NASDAQ:ASTH) Given Consensus Rating of “Moderate Buy” by Brokerages: Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) has been given a consensus rating of “Moderate Buy” by the ten research firms that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-05-16 02:59:04
Astrana Health, Inc. (NASDAQ:ASTH) Position Reduced by Voya Investment Management LLC: Voya Investment Management LLC reduced its position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 7.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 13,038 shares of the company’s stock after selling 979 shares during the quarter. Voya Investment […] - 2025-05-11 06:06:57
Dimensional Fund Advisors LP Buys 101,192 Shares of Astrana Health, Inc. (NASDAQ:ASTH): Dimensional Fund Advisors LP lifted its position in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 10.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,045,540 shares of the company’s stock after buying an additional 101,192 shares during the quarter. Dimensional […] - 2025-05-06 04:59:00
First Trust Advisors LP Has $3.39 Million Stock Position in Astrana Health, Inc. (NASDAQ:ASTH): First Trust Advisors LP increased its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 702.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 107,343 shares of the company’s stock after buying an additional 93,969 shares during the quarter. First Trust […] - 2025-05-04 05:30:52
Astrana Health, Inc. (NASDAQ:ASTH) Shares Purchased by Wells Fargo & Company MN: Wells Fargo & Company MN boosted its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 41.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,484 shares of the company’s stock after buying an additional 6,596 shares […] - 2025-05-02 05:00:57
Barclays PLC Buys 2,627 Shares of Astrana Health, Inc. (NASDAQ:ASTH): Barclays PLC increased its stake in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 79,543 shares of the company’s stock after buying an additional 2,627 shares during the quarter. Barclays PLC’s […] - 2025-05-01 05:12:57
Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) Price Target at $53.29: Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating […] - 2025-04-24 02:10:51
Astrana Health, Inc. (NASDAQ:ASTH) Stock Position Decreased by Corebridge Financial Inc.: Corebridge Financial Inc. lowered its holdings in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 7.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 22,890 shares of the company’s stock after selling 1,784 shares during the period. Corebridge Financial Inc.’s holdings in Astrana Health were worth $722,000 as of its most recent filing with […] - 2025-04-07 04:32:48
Astrana Health (NASDAQ:ASTH) Coverage Initiated at Barclays: Equities researchers at Barclays initiated coverage on shares of Astrana Health (NASDAQ:ASTH – Get Free Report) in a note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage set an “equal weight” rating and a $36.00 price target on the stock. Barclays‘s price objective suggests a potential upside of 19.92% from the company’s current […] - 2025-04-03 02:54:45
Thrivent Financial for Lutherans Sells 487 Shares of Astrana Health, Inc. (NASDAQ:ASTH): Thrivent Financial for Lutherans reduced its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 1.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 32,130 shares of the company’s stock after selling 487 shares during the period. Thrivent Financial for Lutherans’ holdings in […] - 2025-04-02 05:14:57
Natixis Advisors LLC Has $762,000 Position in Astrana Health, Inc. (NASDAQ:ASTH): Natixis Advisors LLC cut its position in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 13.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 24,160 shares of the company’s stock after selling 3,820 shares during the period. Natixis Advisors LLC’s holdings in Astrana Health […] - 2025-03-27 07:08:51
Zurcher Kantonalbank Zurich Cantonalbank Increases Stake in Astrana Health, Inc. (NASDAQ:ASTH): Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 348.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 37,788 shares of the company’s stock after purchasing an additional 29,355 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank […] - 2025-03-20 06:22:51
Truist Financial Lowers Astrana Health (NASDAQ:ASTH) Price Target to $46.00: Astrana Health (NASDAQ:ASTH – Get Free Report) had its price objective reduced by equities research analysts at Truist Financial from $50.00 to $46.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s target price points to a potential upside of 45.99% from the company’s […] - 2025-03-20 03:52:45
Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Down 23.0% in February: Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 1,440,000 shares, a drop of 23.0% from the February 13th total of 1,870,000 shares. Based on an average daily volume of 346,500 shares, the short-interest ratio […] - 2025-03-17 04:10:45
Critical Analysis: Astrana Health (NASDAQ:ASTH) and Exponent (NASDAQ:EXPO): Astrana Health (NASDAQ:ASTH – Get Free Report) and Exponent (NASDAQ:EXPO – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, institutional ownership, dividends, valuation and earnings. Earnings and Valuation This table compares Astrana Health and […] - 2025-03-10 04:08:48

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc ASTH holdings

Date	Number of ASTH Shares Held	Base Market Value of ASTH Shares	Local Market Value of ASTH Shares	Change in ASTH Shares Held	Change in ASTH Base Value	Current Price per ASTH Share Held	Previous Price per ASTH Share Held
2025-11-12 (Wednesday)	6,038	USD 142,255	USD 142,255	-19	USD -1,902	USD 23.56	USD 23.8001
2025-11-11 (Tuesday)	6,057	USD 144,157	USD 144,157	0	USD 8,298	USD 23.8001	USD 22.4301
2025-11-10 (Monday)	6,057	USD 135,859	USD 135,859	0	USD -18,806	USD 22.4301	USD 25.5349
2025-11-07 (Friday)	6,057	USD 154,665	USD 154,665	0	USD -47,397	USD 25.5349	USD 33.3601
2025-11-06 (Thursday)	6,057	USD 202,062	USD 202,062	-19	USD 96	USD 33.3601	USD 33.24
2025-11-05 (Wednesday)	6,076	USD 201,966	USD 201,966	-190	USD -5,439	USD 33.24	USD 33.1001
2025-11-04 (Tuesday)	6,266	USD 207,405	USD 207,405	-38	USD -564	USD 33.1001	USD 32.99
2025-11-03 (Monday)	6,304	USD 207,969	USD 207,969	-38	USD 10,035	USD 32.99	USD 31.21
2025-10-31 (Friday)	6,342	USD 197,934	USD 197,934	0	USD -3,805	USD 31.21	USD 31.81
2025-10-30 (Thursday)	6,342	USD 201,739	USD 201,739	0	USD -9,133	USD 31.81	USD 33.2501
2025-10-29 (Wednesday)	6,342	USD 210,872	USD 210,872	0	USD -4,058	USD 33.2501	USD 33.8899
2025-10-28 (Tuesday)	6,342	USD 214,930	USD 214,930	57	USD 7,211	USD 33.8899	USD 33.05
2025-10-27 (Monday)	6,285	USD 207,719	USD 207,719	0	USD -1,572	USD 33.05	USD 33.3001

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ASTH by Blackrock for IE00B3VWM098

Show aggregate share trades of ASTH

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 SELL -19 24.490 23.316 23.433 USD -445 32.89 Profit of 180 on sale
2025-11-06 SELL -19 34.180 32.850 32.983 USD -627 33.03 Profit of 1 on sale
2025-11-05 SELL -190 33.615 32.190 32.332 USD -6,143 33.02 Profit of 132 on sale
2025-11-04 SELL -38 33.900 32.740 32.856 USD -1,249 33.02 Profit of 6 on sale
2025-11-03 SELL -38 33.650 31.800 31.985 USD -1,215 33.02 Profit of 40 on sale
2025-10-28 BUY 57 33.890 34.800 34.709 USD 1,978 33.03
2025-10-24 SELL -19 33.300 33.960 33.894 USD -644 33.03 Loss of -16 on sale
2025-10-15 BUY 114 30.480 30.490 30.489 USD 3,476 33.06
2025-10-02 BUY 19 27.770 28.420 28.355 USD 539 33.11
2025-09-30 BUY 38 28.350 29.290 29.196 USD 1,109 33.17
2025-09-11 BUY 76 30.380 30.550 30.533 USD 2,321 33.29
2025-08-21 SELL -19 29.970 30.180 30.159 USD -573 33.31 Profit of 60 on sale
2025-07-31 BUY 57 23.860 24.210 24.175 USD 1,378 33.39
2025-06-30 SELL -38 24.880 25.420 25.366 USD -964 34.57 Profit of 350 on sale
2025-06-25 SELL -19 25.040 26.540 26.390 USD -501 34.77 Profit of 159 on sale
2025-06-20 SELL -38 24.000 24.520 24.468 USD -930 34.98 Profit of 399 on sale
2025-05-23 BUY 19 24.290 24.610 24.578 USD 467 36.62
2025-05-19 SELL -19 26.850 27.170 27.138 USD -516 36.99 Profit of 187 on sale
2025-05-15 SELL -57 27.060 27.510 27.465 USD -1,566 37.16 Profit of 552 on sale
2025-05-12 SELL -19 28.540 30.860 30.628 USD -582 37.42 Profit of 129 on sale
2025-05-09 SELL -19 29.710 32.610 32.320 USD -614 37.49 Profit of 98 on sale
2025-04-30 SELL -19 31.170 31.500 31.467 USD -598 37.85 Profit of 121 on sale
2025-04-24 SELL -38 31.400 31.470 31.463 USD -1,196 38.13 Profit of 253 on sale
2025-04-17 SELL -19 31.380 33.030 32.865 USD -624 38.52 Profit of 107 on sale
2025-04-15 SELL -57 33.760 34.150 34.111 USD -1,944 38.63 Profit of 258 on sale
2025-04-14 SELL -57 34.050 34.090 34.086 USD -1,943 38.68 Profit of 262 on sale
2025-04-09 SELL -76 31.930 33.890 33.694 USD -2,561 38.89 Profit of 395 on sale
2025-04-07 SELL -133 29.290 30.950 30.784 USD -4,094 39.09 Profit of 1,105 on sale
2025-04-04 SELL -190 30.070 30.340 30.313 USD -5,759 39.20 Profit of 1,688 on sale
2025-03-31 BUY 19 31.010 31.390 31.352 USD 596 39.52
2025-03-19 SELL -38 31.510 32.000 31.951 USD -1,214 40.42 Profit of 322 on sale
2025-03-14 SELL -114 29.340 30.640 30.510 USD -3,478 40.83 Profit of 1,176 on sale
2025-03-13 SELL -38 29.200 30.100 30.010 USD -1,140 40.99 Profit of 417 on sale
2025-03-12 SELL -646 29.660 29.940 29.912 USD -19,323 41.15 Profit of 7,260 on sale
2025-03-07 SELL -38 29.380 29.730 29.695 USD -1,128 41.70 Profit of 456 on sale
2025-03-06 SELL -57 27.210 27.310 27.300 USD -1,556 41.92 Profit of 834 on sale
2025-03-03 SELL -19 26.480 27.190 27.119 USD -515 42.64 Profit of 295 on sale
2025-02-28 SELL -114 25.380 31.210 30.627 USD -3,491 42.92 Profit of 1,402 on sale
2025-02-26 SELL -19 35.100 36.200 36.090 USD -686 43.19 Profit of 135 on sale
2025-02-25 SELL -57 35.370 35.970 35.910 USD -2,047 43.32 Profit of 422 on sale
2025-02-18 BUY 95 38.900 39.970 39.863 USD 3,787 43.99
2025-02-13 BUY 19 39.200 39.840 39.776 USD 756 44.28
2025-02-12 BUY 19 38.380 38.590 38.569 USD 733 44.40
2025-02-11 BUY 57 38.040 38.500 38.454 USD 2,192 44.54
2025-02-06 BUY 171 35.580 36.840 36.714 USD 6,278 45.10
2025-01-27 BUY 19 37.720 38.890 38.773 USD 737 46.85
2024-12-30 BUY 95 31.980 32.930 32.835 USD 3,119 48.31
2024-12-06 BUY 76 41.410 43.300 43.111 USD 3,276 49.11
2024-12-05 BUY 19 42.900 43.700 43.620 USD 829 49.33
2024-12-04 BUY 95 43.420 44.160 44.086 USD 4,188 49.54
2024-11-29 BUY 95 43.250 43.550 43.520 USD 4,134 50.23
2024-11-27 BUY 76 42.860 44.220 44.084 USD 3,350 50.88
2024-11-26 BUY 19 42.460 43.170 43.099 USD 819 51.26
2024-11-21 BUY 95 42.110 42.380 42.353 USD 4,024 52.69
2024-11-20 BUY 57 41.040 41.290 41.265 USD 2,352 53.33
2024-11-18 BUY 228 40.510 41.320 41.239 USD 9,402 54.91
2024-11-12 BUY 152 42.910 46.740 46.357 USD 7,046 55.71
2024-11-08 BUY 95 46.960 57.420 56.374 USD 5,356 56.34
2024-11-07 BUY 285 59.080 60.910 60.727 USD 17,307 56.12
2024-11-06 BUY 38 59.490 60.990 60.840 USD 2,312 55.84
2024-10-31 BUY 19 53.780 55.550 55.373 USD 1,052 56.44
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	SELL	-19	24.490	23.316	23.433	USD -445	32.89 Profit of 180 on sale
2025-11-06	SELL	-19	34.180	32.850	32.983	USD -627	33.03 Profit of 1 on sale
2025-11-05	SELL	-190	33.615	32.190	32.332	USD -6,143	33.02 Profit of 132 on sale
2025-11-04	SELL	-38	33.900	32.740	32.856	USD -1,249	33.02 Profit of 6 on sale
2025-11-03	SELL	-38	33.650	31.800	31.985	USD -1,215	33.02 Profit of 40 on sale
2025-10-28	BUY	57	33.890	34.800	34.709	USD 1,978	33.03
2025-10-24	SELL	-19	33.300	33.960	33.894	USD -644	33.03 Loss of -16 on sale
2025-10-15	BUY	114	30.480	30.490	30.489	USD 3,476	33.06
2025-10-02	BUY	19	27.770	28.420	28.355	USD 539	33.11
2025-09-30	BUY	38	28.350	29.290	29.196	USD 1,109	33.17
2025-09-11	BUY	76	30.380	30.550	30.533	USD 2,321	33.29
2025-08-21	SELL	-19	29.970	30.180	30.159	USD -573	33.31 Profit of 60 on sale
2025-07-31	BUY	57	23.860	24.210	24.175	USD 1,378	33.39
2025-06-30	SELL	-38	24.880	25.420	25.366	USD -964	34.57 Profit of 350 on sale
2025-06-25	SELL	-19	25.040	26.540	26.390	USD -501	34.77 Profit of 159 on sale
2025-06-20	SELL	-38	24.000	24.520	24.468	USD -930	34.98 Profit of 399 on sale
2025-05-23	BUY	19	24.290	24.610	24.578	USD 467	36.62
2025-05-19	SELL	-19	26.850	27.170	27.138	USD -516	36.99 Profit of 187 on sale
2025-05-15	SELL	-57	27.060	27.510	27.465	USD -1,566	37.16 Profit of 552 on sale
2025-05-12	SELL	-19	28.540	30.860	30.628	USD -582	37.42 Profit of 129 on sale
2025-05-09	SELL	-19	29.710	32.610	32.320	USD -614	37.49 Profit of 98 on sale
2025-04-30	SELL	-19	31.170	31.500	31.467	USD -598	37.85 Profit of 121 on sale
2025-04-24	SELL	-38	31.400	31.470	31.463	USD -1,196	38.13 Profit of 253 on sale
2025-04-17	SELL	-19	31.380	33.030	32.865	USD -624	38.52 Profit of 107 on sale
2025-04-15	SELL	-57	33.760	34.150	34.111	USD -1,944	38.63 Profit of 258 on sale
2025-04-14	SELL	-57	34.050	34.090	34.086	USD -1,943	38.68 Profit of 262 on sale
2025-04-09	SELL	-76	31.930	33.890	33.694	USD -2,561	38.89 Profit of 395 on sale
2025-04-07	SELL	-133	29.290	30.950	30.784	USD -4,094	39.09 Profit of 1,105 on sale
2025-04-04	SELL	-190	30.070	30.340	30.313	USD -5,759	39.20 Profit of 1,688 on sale
2025-03-31	BUY	19	31.010	31.390	31.352	USD 596	39.52
2025-03-19	SELL	-38	31.510	32.000	31.951	USD -1,214	40.42 Profit of 322 on sale
2025-03-14	SELL	-114	29.340	30.640	30.510	USD -3,478	40.83 Profit of 1,176 on sale
2025-03-13	SELL	-38	29.200	30.100	30.010	USD -1,140	40.99 Profit of 417 on sale
2025-03-12	SELL	-646	29.660	29.940	29.912	USD -19,323	41.15 Profit of 7,260 on sale
2025-03-07	SELL	-38	29.380	29.730	29.695	USD -1,128	41.70 Profit of 456 on sale
2025-03-06	SELL	-57	27.210	27.310	27.300	USD -1,556	41.92 Profit of 834 on sale
2025-03-03	SELL	-19	26.480	27.190	27.119	USD -515	42.64 Profit of 295 on sale
2025-02-28	SELL	-114	25.380	31.210	30.627	USD -3,491	42.92 Profit of 1,402 on sale
2025-02-26	SELL	-19	35.100	36.200	36.090	USD -686	43.19 Profit of 135 on sale
2025-02-25	SELL	-57	35.370	35.970	35.910	USD -2,047	43.32 Profit of 422 on sale
2025-02-18	BUY	95	38.900	39.970	39.863	USD 3,787	43.99
2025-02-13	BUY	19	39.200	39.840	39.776	USD 756	44.28
2025-02-12	BUY	19	38.380	38.590	38.569	USD 733	44.40
2025-02-11	BUY	57	38.040	38.500	38.454	USD 2,192	44.54
2025-02-06	BUY	171	35.580	36.840	36.714	USD 6,278	45.10
2025-01-27	BUY	19	37.720	38.890	38.773	USD 737	46.85
2024-12-30	BUY	95	31.980	32.930	32.835	USD 3,119	48.31
2024-12-06	BUY	76	41.410	43.300	43.111	USD 3,276	49.11
2024-12-05	BUY	19	42.900	43.700	43.620	USD 829	49.33
2024-12-04	BUY	95	43.420	44.160	44.086	USD 4,188	49.54
2024-11-29	BUY	95	43.250	43.550	43.520	USD 4,134	50.23
2024-11-27	BUY	76	42.860	44.220	44.084	USD 3,350	50.88
2024-11-26	BUY	19	42.460	43.170	43.099	USD 819	51.26
2024-11-21	BUY	95	42.110	42.380	42.353	USD 4,024	52.69
2024-11-20	BUY	57	41.040	41.290	41.265	USD 2,352	53.33
2024-11-18	BUY	228	40.510	41.320	41.239	USD 9,402	54.91
2024-11-12	BUY	152	42.910	46.740	46.357	USD 7,046	55.71
2024-11-08	BUY	95	46.960	57.420	56.374	USD 5,356	56.34
2024-11-07	BUY	285	59.080	60.910	60.727	USD 17,307	56.12
2024-11-06	BUY	38	59.490	60.990	60.840	USD 2,312	55.84
2024-10-31	BUY	19	53.780	55.550	55.373	USD 1,052	56.44

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ASTH

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	50,959	0	96,426	52.8%
2025-09-18	37,098	0	80,558	46.1%
2025-09-17	27,760	0	69,291	40.1%
2025-09-16	72,326	0	116,349	62.2%
2025-09-15	50,724	0	94,484	53.7%
2025-09-12	29,941	0	64,177	46.7%
2025-09-11	55,980	100	134,234	41.7%
2025-09-10	77,074	0	111,324	69.2%
2025-09-09	70,632	0	204,672	34.5%
2025-09-08	76,236	0	163,072	46.7%
2025-09-05	59,589	0	128,052	46.5%
2025-09-04	43,870	0	85,113	51.5%
2025-09-03	79,835	0	138,753	57.5%
2025-09-02	42,846	0	93,151	46.0%
2025-08-29	57,842	0	111,838	51.7%
2025-08-28	69,827	52	130,510	53.5%
2025-08-27	50,219	0	98,504	51.0%
2025-08-26	62,692	0	88,639	70.7%
2025-08-25	57,225	0	152,249	37.6%
2025-08-22	37,470	360	92,757	40.4%
2025-08-21	63,374	835	171,855	36.9%
2025-08-20	29,940	0	83,914	35.7%
2025-08-19	41,553	0	69,473	59.8%
2025-08-18	60,928	0	115,063	53.0%
2025-08-15	58,441	0	125,017	46.7%
2025-08-14	80,679	0	164,634	49.0%
2025-08-13	80,991	0	170,055	47.6%
2025-08-12	107,614	0	196,903	54.7%
2025-08-11	151,507	1	339,464	44.6%
2025-08-08	371,412	901	775,554	47.9%
2025-08-07	88,878	0	147,656	60.2%
2025-08-06	80,350	0	127,017	63.3%
2025-08-05	104,795	0	162,998	64.3%
2025-08-04	71,432	12,053	145,199	49.2%
2025-08-01	147,722	4,091	224,024	65.9%
2025-07-31	84,609	0	120,013	70.5%
2025-07-30	87,774	0	175,517	50.0%
2025-07-29	96,866	0	170,112	56.9%
2025-07-28	44,441	0	126,763	35.1%
2025-07-25	58,843	0	110,158	53.4%
2025-07-24	75,053	0	115,936	64.7%
2025-07-23	55,012	0	92,181	59.7%
2025-07-22	64,822	2,807	89,832	72.2%
2025-07-21	48,296	0	82,927	58.2%
2025-07-18	104,673	0	154,385	67.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE